<DOC>
	<DOCNO>NCT02997982</DOCNO>
	<brief_summary>This study investigate effect Valaciclovir treatment individual Alzheimer 's disease Mild Cognitive Impairment Alzheimer 's Disease Type . It open pilot trial 36 participant receive 4 week Valaciclovir treatment . Participants investigate use different measure treatment period .</brief_summary>
	<brief_title>Feasibility Effects Valaciclovir Treatment Persons With Early Alzheimer 's Disease</brief_title>
	<detailed_description>This study investigate effect valaciclovir treatment individual Alzheimer 's disease ( AD ) Mild Cognitive Impairment Alzheimer 's Disease Type . It open pilot trial 36 participant receive 4 week oral valaciclovir treatment . To find 36 person fulfil inclusion criterion , 120 person screen . Important inclusion criterion Herpes Simplex Virus ( HSV ) Immunoglobulin G ( IgG ) -positivity ( HSV carriage ) , Apolipoprotein E allele 4 carriage sufficient kidney function ( estimate glomerular filtration rate 30 ml/min ) . All participant must give informed consent participation . The valaciclovir dose 500 mg three time daily first week 1000 mg three time daily week 2-4 . Participants investigate use different measure treatment period : Mini Mental State Examination assess cognitive function , Cerebrospinal fluid biomarkers Alzheimer 's disease [ 18F ] -FHBG-PET/CT ( 9- [ 4- [ 18F ] fluoro-3- ( hydroxymethyl ) butyl ] guanine positron emission tomography/computed tomography ) ) possibly indicate active HSV infection within central nervous system .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Man woman , age ≥ 65 year Ability take stand make sign inform consent participate study . This imply person MMSE ( Mini Mental State Examination ) &lt; 18 probably include . Diagnosed Alzheimer 's disease mild cognitive impairment due Alzheimer 's disease . At least one brain imaging examination do ( CT , MR , SPECT PET/CT ) least one objective find support diagnosis beyond specific medical history . Reduced perfusion reduce metabolism bilaterally temporally , hippocampal atrophy pathological marker Alzheimer 's disease cerebrospinal fluid finding . Persons vascular brain disorder e.g . severe white matter change previous brain infarction include white matter change consider normal age include . Positive antiHSV ( Herpes Simplex Virus ) Immunoglobulin G ( IgG ) plasma , i.e . carrier HSV . Hetero Homozygote allele 4 gene Apolipoprotein E. Stable medication include medication Alzheimer 's disease ( rivastigmine , galantamin , donepezil memantin ) least one month . No known allergy oversensitivity valaciclovir aciclovir . Ability independently support relative caretaker comply study drug . Renal insufficiency estimate GFR ( Glomerular Filtration Rate ) ≤ 30 ml/min/1.73m2 Ongoing treatment anticoagulant ( Warfarin , low molecular heparin anticoagulant agent ) . Antiplatelet agent recommend dose accept ( i.e . Acetylsalicylic acid 75 mgx1 ) Life expectancy &lt; 1 year due comorbidity Ongoing severe somatic condition might interfere patient participation study ( i.e . ongoing cancer treatment ) Ongoing illness make exams supine position impossible ( i.e . severe heart failure , severe back pain ) . Dementia diagnosis Alzheimer 's disease , include Vascular dementia . Other known neurological/neurodegenerative disorder ( i.e . brain tumor , MS ( Multiple sclerosis ) , ALS ( amyotrophic lateral sclerosis ) ) Claustrophobia contraindication PET/CT scanning . Depression psychiatric illness require treatment ( i.e . severe psychosis illness equal grade seriousness ) Dementia cognitive dysfunction extent inform consent impossible obtain , correspond MMSESR ( Mini Mental State ExaminationSwedish revision ) &lt; 18 . History substance abuse ( i.e . central nervous system stimulant alcohol ) . Nicotine use accept . Not willing participate study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Herpes Simplex Virus</keyword>
	<keyword>HSV</keyword>
	<keyword>Antiviral Drugs</keyword>
</DOC>